Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : XOMA. Bull or Bear? -- Ignore unavailable to you. Want to Upgrade?

To: aknahow who wrote (7838)	11/25/1998 3:58:00 PM
From: Webhead	Read Replies (1) \| Respond to of 17367

As a former supporter of the "surfactant issue" I certainly feel that with the proper formulations/binders/etc... BPI peptides might find great use in stents and catheters. Though I forget the name of the compay, about a year ago there was a grand announcement about the development of a stent coated with some time-release antibiotic. Apparently there is a lot of difficulty in keeping catheters sterile for long term use and leads to major and expensive problems. So don't discount the possibilities yet! You'll know Xoma has made it big when BPI peptides make it into toothpaste and contact lens solution! BPI deoderant?!? (really, I'm only half kidding. If production costs of peptides drops due to new technologies there may be many opportunities for BPI that now appear too expensive...) Ed